CompletedPhase 2NCT00626678
Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
Studying Pemphigus vulgaris
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Tehran University of Medical Sciences
- Principal Investigator
- Cheyda Chams-Davatchi, MDTehran University of Medical Sciences
- Intervention
- Azathioprine(drug)
- Enrollment
- 48 target
- Eligibility
- 10-75 years · All sexes
- Timeline
- 2008 – 2010
Study locations (1)
- Department of Dermatology, Tehran University of Medical Sciences, Tehran, Tehran Province, Iran
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00626678 on ClinicalTrials.govOther trials for Pemphigus vulgaris
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07384221Periodontal Status and Disease Severity in Pemphigus Vulgaris PatientsSaglik Bilimleri Universitesi
- RECRUITINGPHASE1, PHASE2NCT04422912A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)Cabaletta Bio
- RECRUITINGNCT02753777Autoimmune Blistering Diseases StudyUniversity of Pennsylvania